CCL2 and metabolic dysfunction-associated steatohepatitis: Changes in inflammatory cell populations are associated with activation and secretion of various cytokines such as TNFα, IL-6, MCP-1, IL-10, have been shown to be elevated in patient serum samples in the setting of NASH [9], [19]–[21].